Healthcare provider profile · identity verified

Jesus Lua, M.D.

Family Practice · UPLAND, CA · NPI 1992776108

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	656	134
Metformin Hcl	Metformin Hcl	448	76
Amlodipine Besylate	Amlodipine Besylate	346	54
Hydrochlorothiazide	Hydrochlorothiazide	273	43
Alendronate Sodium	Alendronate Sodium	260	48
Losartan Potassium	Losartan Potassium	241	44
Lisinopril	Lisinopril	234	43
Gabapentin	Gabapentin	230	40
Acarbose	Acarbose	205	39
Pioglitazone Hcl	Pioglitazone Hcl	182	32
Famotidine	Famotidine	181	44
Levothyroxine Sodium	Levothyroxine Sodium	180	35
Meloxicam	Meloxicam	173	34
Carvedilol	Carvedilol	154	27
Trazodone Hcl	Trazodone Hcl	146	29
Ibuprofen	Ibuprofen	138	36
Glipizide	Glipizide	137	27
Tamsulosin Hcl	Tamsulosin Hcl	137	25
Tramadol Hcl	Tramadol Hcl	131	25
Omeprazole	Omeprazole	126	23
Metoprolol Tartrate	Metoprolol Tartrate	123	20
Pantoprazole Sodium	Pantoprazole Sodium	123	26
Escitalopram Oxalate	Escitalopram Oxalate	119	25
Cephalexin	Cephalexin	108	75
Diclofenac Sodium	Diclofenac Sodium	106	38
Irbesartan	Irbesartan	103	16
Simvastatin	Simvastatin	103	20
Ezetimibe	Ezetimibe	98	31
Baclofen	Baclofen	88	24
Alcohol Prep Pads	Alcohol Antiseptic Pads	84	15
Rosuvastatin Calcium	Rosuvastatin Calcium	82	17
Nateglinide	Nateglinide	79	suppressed
Clonazepam	Clonazepam	78	11
Furosemide	Furosemide	77	12
Azithromycin	Azithromycin	70	49
Jardiance	Empagliflozin	69	15
Albuterol Sulfate Hfa	Albuterol Sulfate	62	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	61	suppressed
Alprazolam	Alprazolam	59	14
Fenofibrate	Fenofibrate	59	16
Celecoxib	Celecoxib	58	21
Hydralazine Hcl	Hydralazine Hcl	57	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	56	16
Benazepril Hcl	Benazepril Hcl	55	15
Finasteride	Finasteride	55	suppressed
Montelukast Sodium	Montelukast Sodium	55	suppressed
Metoprolol Succinate	Metoprolol Succinate	54	suppressed
Sertraline Hcl	Sertraline Hcl	54	13
Clopidogrel	Clopidogrel Bisulfate	53	suppressed
Januvia	Sitagliptin Phosphate	53	suppressed
Ozempic	Semaglutide	53	suppressed
Amoxicillin	Amoxicillin	52	38
Paroxetine Hcl	Paroxetine Hcl	52	11
Oxybutynin Chloride	Oxybutynin Chloride	51	13
Mirtazapine	Mirtazapine	50	11
Enalapril Maleate	Enalapril Maleate	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	18
Lorazepam	Lorazepam	44	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	suppressed
Glimepiride	Glimepiride	39	suppressed
Prednisone	Prednisone	39	28
Donepezil Hcl	Donepezil Hcl	38	11
Lovastatin	Lovastatin	38	11
Myrbetriq	Mirabegron	37	suppressed
True Comfort Safety Pen Needle	Pen Needle, Diabetic, Safety	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Lidocaine	Lidocaine	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Atenolol	Atenolol	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Eliquis	Apixaban	27	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Naproxen	Naproxen	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Digoxin	Digoxin	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Ciclopirox	Ciclopirox	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Calcitriol	Calcitriol	16	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Temazepam	Temazepam	15	suppressed
Acyclovir	Acyclovir	14	11
Briviact	Brivaracetam	14	suppressed
Dapagliflozin	Dapagliflozin Propanediol	14	suppressed
Estradiol	Estradiol	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Linzess	Linaclotide	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bicalutamide	Bicalutamide	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Invokana	Canagliflozin	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Metronidazole	Metronidazole	12	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Alogliptin	Alogliptin Benzoate	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error